Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.
2.

The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.

Rim MY, Ro H, Kang WC, Kim AJ, Park H, Chang JH, Lee HH, Chung W, Jung JY.

Am J Kidney Dis. 2012 Oct;60(4):576-82. doi: 10.1053/j.ajkd.2012.04.017. Epub 2012 May 31. Erratum in: Am J Kidney Dis. 2013 May;61(5):849.

PMID:
22658321
3.

Therapeutic strategies to prevent contrast-induced acute kidney injury.

Quintavalle C, Donnarumma E, Fiore D, Briguori C, Condorelli G.

Curr Opin Cardiol. 2013 Nov;28(6):676-82. doi: 10.1097/HCO.0b013e3283653f41. Review.

PMID:
24077605
4.

Contrast-induced acute kidney injury: how much contrast is safe?

Keaney JJ, Hannon CM, Murray PT.

Nephrol Dial Transplant. 2013 Jun;28(6):1376-83. doi: 10.1093/ndt/gfs602. Epub 2013 Feb 14. Review.

5.

The efficacy of diuretics in acute and chronic renal failure. Focus on torasemide.

Risler T, Krämer B, Müller GA.

Drugs. 1991;41 Suppl 3:69-79. Review.

PMID:
1712716
6.
7.

Incidence, morbidity, and mortality of contrast-induced acute kidney injury in a surgical intensive care unit: a prospective cohort study.

Valette X, Parienti JJ, Plaud B, Lehoux P, Samba D, Hanouz JL.

J Crit Care. 2012 Jun;27(3):322.e1-5. doi: 10.1016/j.jcrc.2011.08.005. Epub 2011 Oct 26.

PMID:
22033061
8.

[Torasemide (LUPRAC): a review of its pharmacological and clinical profile].

Kido H, Ohtaki Y.

Nihon Yakurigaku Zasshi. 2001 Aug;118(2):97-105. Review. Japanese.

PMID:
11530685
9.

Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury.

Caixeta A, Mehran R.

Catheter Cardiovasc Interv. 2010 Mar 1;75 Suppl 1:S15-20. doi: 10.1002/ccd.22376. Review.

PMID:
20333702
10.

Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.

Song K, Jiang S, Shi Y, Shen H, Shi X, Jing D.

Am J Nephrol. 2010;32(5):497-504. doi: 10.1159/000321344. Epub 2010 Oct 26. Erratum in: Am J Nephrol. 2011;34(2):173; author reply 174.

11.

Diuretics in acute kidney injury.

Karajala V, Mansour W, Kellum JA.

Minerva Anestesiol. 2009 May;75(5):251-7. Epub 2008 Jul 18. Review.

12.

The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.

Bolognese L, Falsini G, Grotti S, Limbruno U, Liistro F, Carrera A, Angioli P, Picchi A, Ducci K, Pierli C.

J Cardiovasc Med (Hagerstown). 2010 Mar;11(3):199-206. doi: 10.2459/JCM.0b013e32833186a4.

PMID:
19829124
13.

Three feasible strategies to minimize kidney injury in 'incipient AKI'.

Perazella MA, Coca SG.

Nat Rev Nephrol. 2013 Aug;9(8):484-90. doi: 10.1038/nrneph.2013.80. Epub 2013 May 7.

PMID:
23649020
14.

Anti-aldosteronergic effect of torasemide.

Uchida T, Yamanaga K, Nishikawa M, Ohtaki Y, Kido H, Watanabe M.

Eur J Pharmacol. 1991 Nov 26;205(2):145-50.

PMID:
1812004
15.

Hemodynamic and tubular changes induced by contrast media.

Caiazza A, Russo L, Sabbatini M, Russo D.

Biomed Res Int. 2014;2014:578974. doi: 10.1155/2014/578974. Epub 2014 Feb 11. Review.

17.

Prevention of contrast-induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: randomized comparison of two preventive strategies.

Hafiz AM, Jan MF, Mori N, Shaikh F, Wallach J, Bajwa T, Allaqaband S.

Catheter Cardiovasc Interv. 2012 May 1;79(6):929-37. doi: 10.1002/ccd.23148. Epub 2011 Dec 8.

PMID:
21542114
18.

Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, Hong MK, Jang Y.

Heart. 2011 Nov;97(21):1753-7. doi: 10.1136/hrt.2010.218677. Epub 2011 May 20.

PMID:
21602521
19.

Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis.

James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P, Knudtson ML, Pannu N, Hemmelgarn BR.

Circ Cardiovasc Interv. 2013 Feb;6(1):37-43. doi: 10.1161/CIRCINTERVENTIONS.112.974493. Epub 2013 Jan 15. Review.

20.

Torasemide. An update of its pharmacological properties and therapeutic efficacy.

Dunn CJ, Fitton A, Brogden RN.

Drugs. 1995 Jan;49(1):121-42. Review.

PMID:
7705212
Items per page

Supplemental Content

Write to the Help Desk